THERAPEUTIC FOCUS

We focus on development of novel and breakthrough therapies for unmet medical needs in any therapeutic area where a scientific, medical and business opportunity arises.

Areas of our interest are:

  • Orphan diseases
  • Immune and autoimmune diseases
  • Cancer
  • Neurological disorders

Currently we have under development a drug for a serious autoimmune condition:

 

AUR-1001 IS THE FIRST IN CLASS COMPOUND FOR THE TREATMENT OF ANTIPHOSPHOLIPID SYNDROME (HUGHES SYNDROME)